<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>Jahrom University of Medical Sciences</PublisherName>
				<JournalTitle>Pars Journal of Medical Sciences</JournalTitle>
				<Issn>2717-0284</Issn>
				<Volume>20</Volume>
				<Issue>2</Issue>
				<PubDate PubStatus="epublish">
					<Year>2022</Year>
					<Month>08</Month>
					<Day>23</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Inhibitory effect of the interferon-beta on the release of endothelial cell derived microparticles in patients with multiple sclerosis</ArticleTitle>
<VernacularTitle>Inhibitory effect of the interferon-beta on the release of endothelial cell derived microparticles in patients with multiple sclerosis</VernacularTitle>
			<FirstPage>1</FirstPage>
			<LastPage>9</LastPage>
			<ELocationID EIdType="pii">700533</ELocationID>
			
<ELocationID EIdType="doi">10.22034/pjms.2022.700533</ELocationID>
			
			<Language>FA</Language>
<AuthorList>
<Author>
					<FirstName>Akbar</FirstName>
					<LastName>Hashemi Tayer</LastName>
<Affiliation>Research Center for Noncommunicable Diseases, Jahrom University of Medical Sciences, Jahrom, Iran</Affiliation>
<Identifier Source="ORCID">0000-0001-8007-5552</Identifier>

</Author>
<Author>
					<FirstName>Maryam</FirstName>
					<LastName>Jalali</LastName>
<Affiliation>Research Center for Noncommunicable Diseases, Jahrom University of Medical Sciences, Jahrom, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-9186-9929</Identifier>

</Author>
<Author>
					<FirstName>Maryam</FirstName>
					<LastName>Kamravan</LastName>
<Affiliation>Research Center for Noncommunicable Diseases, Jahrom University of Medical Sciences, Jahrom, Iran</Affiliation>
<Identifier Source="ORCID">0000-0003-3574-6753</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2022</Year>
					<Month>12</Month>
					<Day>25</Day>
				</PubDate>
			</History>
		<Abstract>Introduction: Increased levels of microparticles (MPs) have been reported in many autoimmune diseases such as multiple sclerosis (MS). In MS, endothelial cells release MPs from their membranes following the activation of lymphocytes and the production of inflammatory cytokines. The aim of this study was to investigate the inhibitory effect of interferon beta (INFβ) on the release of endothelial cell-derived MPs (EnMPs).&lt;br /&gt;Material and Methods: Twenty newly diagnosed MS patients were included in this study. Blood samples were taken from&lt;br /&gt;patients in two stages before and three months after INFβ treatment. Flow cytometry was used to count and determine the phenotype of MPs. Anti-CD51 and anti-CD31 were used to tag EnMPs. In both stages, patients&#039; MRI was also evaluated for the number of brain plaques. Data were analyzed using SPSS-23 statistical software.&lt;br /&gt;Result: The mean age of patients was 31.3 ± 8.3 years. The results of this study showed a 40% decrease in the level of CD31+ MPs and a 32% decrease in the level of CD51+ MPs following treatment with INFβ, which was statistically significant (p &lt;0.001). In this study, there was no positive and significant relationship between the number of EnMPs and the number of brain plaques (p = 0.067), age (p = 0.058) and sex of patients (p = 0.061).&lt;br /&gt;Conclusion: INFβ has an inhibitory effect on the release of EnMPs from endothelial cells and suggest that EnMPs can probably be used as sensitive biomarkers to monitor disease progression and treatment effectiveness.&lt;br /&gt;&lt;br /&gt;</Abstract>
			<OtherAbstract Language="FA">Introduction: Increased levels of microparticles (MPs) have been reported in many autoimmune diseases such as multiple sclerosis (MS). In MS, endothelial cells release MPs from their membranes following the activation of lymphocytes and the production of inflammatory cytokines. The aim of this study was to investigate the inhibitory effect of interferon beta (INFβ) on the release of endothelial cell-derived MPs (EnMPs).&lt;br /&gt;Material and Methods: Twenty newly diagnosed MS patients were included in this study. Blood samples were taken from&lt;br /&gt;patients in two stages before and three months after INFβ treatment. Flow cytometry was used to count and determine the phenotype of MPs. Anti-CD51 and anti-CD31 were used to tag EnMPs. In both stages, patients&#039; MRI was also evaluated for the number of brain plaques. Data were analyzed using SPSS-23 statistical software.&lt;br /&gt;Result: The mean age of patients was 31.3 ± 8.3 years. The results of this study showed a 40% decrease in the level of CD31+ MPs and a 32% decrease in the level of CD51+ MPs following treatment with INFβ, which was statistically significant (p &lt;0.001). In this study, there was no positive and significant relationship between the number of EnMPs and the number of brain plaques (p = 0.067), age (p = 0.058) and sex of patients (p = 0.061).&lt;br /&gt;Conclusion: INFβ has an inhibitory effect on the release of EnMPs from endothelial cells and suggest that EnMPs can probably be used as sensitive biomarkers to monitor disease progression and treatment effectiveness.&lt;br /&gt;&lt;br /&gt;</OtherAbstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">multiple sclerosis</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Interferon beta</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Endothelial cell-derived microparticles</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://jmj.jums.ac.ir/article_700533_20dcf61104828d1809a636b9c2e1673e.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Jahrom University of Medical Sciences</PublisherName>
				<JournalTitle>Pars Journal of Medical Sciences</JournalTitle>
				<Issn>2717-0284</Issn>
				<Volume>20</Volume>
				<Issue>2</Issue>
				<PubDate PubStatus="epublish">
					<Year>2022</Year>
					<Month>08</Month>
					<Day>23</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Identification of renal cell carcinoma specific genes and in vitro confirmation of their expression in ACHN cell line in the presence of Staphylococcus aureus toxin SHE</ArticleTitle>
<VernacularTitle>Identification of renal cell carcinoma specific genes and in vitro confirmation of their expression in ACHN cell line in the presence of Staphylococcus aureus toxin SHE</VernacularTitle>
			<FirstPage>10</FirstPage>
			<LastPage>20</LastPage>
			<ELocationID EIdType="pii">700535</ELocationID>
			
<ELocationID EIdType="doi">10.22034/pjms.2022.700535</ELocationID>
			
			<Language>FA</Language>
<AuthorList>
<Author>
					<FirstName>Maryam</FirstName>
					<LastName>Safarpour-Dehkordi</LastName>
<Affiliation>PhD Student at Department of Biology, Faculty of Basic Sciences, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-1134-4568</Identifier>

</Author>
<Author>
					<FirstName>Abbas</FirstName>
					<LastName>Doosti</LastName>
<Affiliation>Associate Professor at Biotechnology Research Center, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran</Affiliation>
<Identifier Source="ORCID">0000-0001-8052-5963</Identifier>

</Author>
<Author>
					<FirstName>Mohammad-Saeid</FirstName>
					<LastName>Jami</LastName>
<Affiliation>Assistant Professor at Department of Biology, Faculty of Basic Sciences, Shahrekord Branch, Islamic Azad
University, Shahrekord, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-5055-5130</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2022</Year>
					<Month>12</Month>
					<Day>25</Day>
				</PubDate>
			</History>
		<Abstract>Introduction: Renal cell carcinoma (RCC) is the most common type of kidney cancer in adults. The aim of the present&lt;br /&gt;study was to obtain specific genes in RCC, based on bioinformatics studies and to evaluate the expression change of candidate genes in ACHN cells after transfection of the seh gene of Staphylococcus aureus.&lt;br /&gt;Material and Methods: The expression correlations of genes involved in RCC were investigated in the TCGA database, and&lt;br /&gt;networks of genes was constructed. In vivo studies were performed in the ACHN cell model, in which the staphylococcal seh gene was cloned into the pcDNA3.1 (+) vector and transfected into ACHN cells. After confirming the correct function of the recombinant vector in these cells and inducing apoptosis, the expression of candidate genes was evaluated.&lt;br /&gt;Results: The results showed the successful identification of the expression correlations of genes involved in apoptosis and lncRNA-mRNA interaction network in RCC. Induction of apoptosis under the influence of toxin expression was confirmed by flow cytometry. Expression of SOX9, SBF2/AS1, MAF and c-Maf genes in cells ordered by recombinant vector was significantly reduced compared to control cells. Also, increased expression of LINC00671 and LINC02499 genes was observed in cells transfected with pcDNA3.1 (+)- seh vector compared to the control group (p&lt;0.05) and This change in expression confirmed the accurate identification of genes involved in RCC cell apoptosis.&lt;br /&gt;Conclusion: The gene networks identified in this study can provide a new perspective for research aimed at identifying new molecular pathways and treating RCC.</Abstract>
			<OtherAbstract Language="FA">Introduction: Renal cell carcinoma (RCC) is the most common type of kidney cancer in adults. The aim of the present&lt;br /&gt;study was to obtain specific genes in RCC, based on bioinformatics studies and to evaluate the expression change of candidate genes in ACHN cells after transfection of the seh gene of Staphylococcus aureus.&lt;br /&gt;Material and Methods: The expression correlations of genes involved in RCC were investigated in the TCGA database, and&lt;br /&gt;networks of genes was constructed. In vivo studies were performed in the ACHN cell model, in which the staphylococcal seh gene was cloned into the pcDNA3.1 (+) vector and transfected into ACHN cells. After confirming the correct function of the recombinant vector in these cells and inducing apoptosis, the expression of candidate genes was evaluated.&lt;br /&gt;Results: The results showed the successful identification of the expression correlations of genes involved in apoptosis and lncRNA-mRNA interaction network in RCC. Induction of apoptosis under the influence of toxin expression was confirmed by flow cytometry. Expression of SOX9, SBF2/AS1, MAF and c-Maf genes in cells ordered by recombinant vector was significantly reduced compared to control cells. Also, increased expression of LINC00671 and LINC02499 genes was observed in cells transfected with pcDNA3.1 (+)- seh vector compared to the control group (p&lt;0.05) and This change in expression confirmed the accurate identification of genes involved in RCC cell apoptosis.&lt;br /&gt;Conclusion: The gene networks identified in this study can provide a new perspective for research aimed at identifying new molecular pathways and treating RCC.</OtherAbstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Kidney Cell Carcinoma</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">bioinformatics analysis</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">SEH toxin</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">ACHN cell line</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://jmj.jums.ac.ir/article_700535_317d89bbfb1f3ae0db9af2eeeec4480d.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Jahrom University of Medical Sciences</PublisherName>
				<JournalTitle>Pars Journal of Medical Sciences</JournalTitle>
				<Issn>2717-0284</Issn>
				<Volume>20</Volume>
				<Issue>2</Issue>
				<PubDate PubStatus="epublish">
					<Year>2022</Year>
					<Month>08</Month>
					<Day>23</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Evaluation of Hyperthermia Effects on Proliferation, Survival, and Gene Expression of Stemness-Related, Wnt signaling, and Apoptosis Pathways in Colorectal Cancer Stem Cell</ArticleTitle>
<VernacularTitle>Evaluation of Hyperthermia Effects on Proliferation, Survival, and Gene Expression of Stemness-Related, Wnt signaling, and Apoptosis Pathways in Colorectal Cancer Stem Cell</VernacularTitle>
			<FirstPage>21</FirstPage>
			<LastPage>30</LastPage>
			<ELocationID EIdType="pii">700538</ELocationID>
			
<ELocationID EIdType="doi">10.22034/pjms.2022.700538</ELocationID>
			
			<Language>FA</Language>
<AuthorList>
<Author>
					<FirstName>Behnaz</FirstName>
					<LastName>Valibeigi</LastName>
<Affiliation>Department of Biology, Marvdasht Branch, Islamic Azad University, Marvdasht, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Abbas</FirstName>
					<LastName>Behzad- Behbahani</LastName>
<Affiliation>Professor, Diagnostic Laboratory Sciences and Technology Research Center, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-0960-7613</Identifier>

</Author>
<Author>
					<FirstName>Mohsen</FirstName>
					<LastName>Forouzanfar</LastName>
<Affiliation>Assistant Professor, Department of Biology, Marvdasht Branch, Islamic Azad University, Marvdasht, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Farzaneh</FirstName>
					<LastName>Zarghampoor</LastName>
<Affiliation>PhD, Diagnostic Laboratory Sciences and Technology Research Center, School of Paramedical Sciences,
Shiraz University of Medical Sciences, Shiraz, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-7266-8312</Identifier>

</Author>
<Author>
					<FirstName>Mojtaba</FirstName>
					<LastName>Jaafarinia</LastName>
<Affiliation>Assistant Professor, Department of Biology, Marvdasht Branch, Islamic Azad University, Marvdasht, Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2022</Year>
					<Month>12</Month>
					<Day>25</Day>
				</PubDate>
			</History>
		<Abstract>Introduction: Today, cancer stem cells have attracted a lot of attention as tumour-initiating cells. Hyperthermia was also found to be beneficial in cancer treatment in many studies. In the present study, we assessed the effects of hyperthermia on colorectal cancer cells (HT-29) and their derived cancer stem cells (CSCs).&lt;br /&gt;Materials and Methods: CSCs were isolated from the HT-29 cell lines and then, the expression of surface marker and stemness-related genes were evaluated. Next, the toxicity effect of hyperthermia on HT-29 and CSCs was assessed. In addition, the effect of hyperthermia on the expression of stemness, proliferation, Wnt signaling pathway, and apoptosis genes was evaluated. Finally, the data were statistically analyzed.&lt;br /&gt;Results: Isolated-CSCs were positive for CD133 surface marker and the expression of stemness genes in the isolated-CSCs was significantly higher than HT-29 cells (P-value&lt; 0.05). Treatment with hyperthermia reduced the survival rate of HT-29 and CSCs. In both groups, the gene expression of OCT3/4, NANOG, PCNA, WNT1, and CTNNB1, was decreased. In addition, the expression of P53, KLF4, and BAX genes was significantly increased in CSCs (P &lt;0.05).&lt;br /&gt;Conclusion: The results showed that hyperthermia did not have a significant effect on HT-29 cells. However, it had a significant effect on the cell viability, growth curve, expression of genes involved in apoptosis and KLF4 in treated-CSCs. Therefore, hyperthermia can have a beneficial effect on inhibiting the growth and proliferation of CSCs.&lt;br /&gt; </Abstract>
			<OtherAbstract Language="FA">Introduction: Today, cancer stem cells have attracted a lot of attention as tumour-initiating cells. Hyperthermia was also found to be beneficial in cancer treatment in many studies. In the present study, we assessed the effects of hyperthermia on colorectal cancer cells (HT-29) and their derived cancer stem cells (CSCs).&lt;br /&gt;Materials and Methods: CSCs were isolated from the HT-29 cell lines and then, the expression of surface marker and stemness-related genes were evaluated. Next, the toxicity effect of hyperthermia on HT-29 and CSCs was assessed. In addition, the effect of hyperthermia on the expression of stemness, proliferation, Wnt signaling pathway, and apoptosis genes was evaluated. Finally, the data were statistically analyzed.&lt;br /&gt;Results: Isolated-CSCs were positive for CD133 surface marker and the expression of stemness genes in the isolated-CSCs was significantly higher than HT-29 cells (P-value&lt; 0.05). Treatment with hyperthermia reduced the survival rate of HT-29 and CSCs. In both groups, the gene expression of OCT3/4, NANOG, PCNA, WNT1, and CTNNB1, was decreased. In addition, the expression of P53, KLF4, and BAX genes was significantly increased in CSCs (P &lt;0.05).&lt;br /&gt;Conclusion: The results showed that hyperthermia did not have a significant effect on HT-29 cells. However, it had a significant effect on the cell viability, growth curve, expression of genes involved in apoptosis and KLF4 in treated-CSCs. Therefore, hyperthermia can have a beneficial effect on inhibiting the growth and proliferation of CSCs.&lt;br /&gt; </OtherAbstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Colorectal cancer</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Hyperthermia</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">and Cancer Stem Cell</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://jmj.jums.ac.ir/article_700538_ed319dbf9b64d75192b77ec3996148e6.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Jahrom University of Medical Sciences</PublisherName>
				<JournalTitle>Pars Journal of Medical Sciences</JournalTitle>
				<Issn>2717-0284</Issn>
				<Volume>20</Volume>
				<Issue>2</Issue>
				<PubDate PubStatus="epublish">
					<Year>2022</Year>
					<Month>08</Month>
					<Day>23</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Evaluation of the relationship of modic change and effusion of facet effects on clinical, functional and stability of spine in operated patients with lumbar degenerative diseases</ArticleTitle>
<VernacularTitle>Evaluation of the relationship of modic change and effusion of facet effects on clinical, functional and stability of spine in operated patients with lumbar degenerative diseases</VernacularTitle>
			<FirstPage>31</FirstPage>
			<LastPage>38</LastPage>
			<ELocationID EIdType="pii">700540</ELocationID>
			
<ELocationID EIdType="doi">10.22034/pjms.2022.700540</ELocationID>
			
			<Language>FA</Language>
<AuthorList>
<Author>
					<FirstName>Seyed Reza</FirstName>
					<LastName>Mousavi</LastName>
<Affiliation>Assistant Professor, Shiraz University of Medical Sciences, Shiraz, Iran</Affiliation>
<Identifier Source="ORCID">0000-0001-8188-3818</Identifier>

</Author>
<Author>
					<FirstName>Azam</FirstName>
					<LastName>Soleimani</LastName>
<Affiliation>Assistant Professor, Kazerun Islamic Azad University of Medical Sciences. Kazerun. Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-1863-6715</Identifier>

</Author>
<Author>
					<FirstName>Majid Reza</FirstName>
					<LastName>Farrokhi</LastName>
<Affiliation>Professor, Shiraz University of Medical Sciences, Shiraz, Iran</Affiliation>
<Identifier Source="ORCID">0000-0003-1252-3215</Identifier>

</Author>
<Author>
					<FirstName>Ataolah</FirstName>
					<LastName>Rouhi</LastName>
<Affiliation>Resident, Shiraz University of Medical Sciences, Shiraz, Iran</Affiliation>
<Identifier Source="ORCID">0000-0003-0559-3629</Identifier>

</Author>
<Author>
					<FirstName>Fatemeh</FirstName>
					<LastName>Karimi</LastName>
<Affiliation>Assistant Professor, Shiraz University of Medical Sciences, Shiraz, Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2022</Year>
					<Month>12</Month>
					<Day>25</Day>
				</PubDate>
			</History>
		<Abstract>Introduction: The aim of this study was to investigate the relationship between Modic changes and facet effusion and&lt;br /&gt;its relationship with lumbar spine stability in patients who underwent surgery for degenerative disorders.&lt;br /&gt;Materials and Methods: This observational study was performed on retrospectively collected data from the records of 116&lt;br /&gt;patients referred to Shahid Chamran Hospital in Shiraz between 2016 and 2019. Patients&#039; records were initially queried for demographic data, facet effusion extent, modic changes and type of operation. Patients underwent clinical examination and imaging after 6 months and spinal stability was assessed. Data analysis was performed using descriptive and inferential statistical tests.&lt;br /&gt;Results: The prevalence of 6-month instability in this study was very low (1 patient, 0.86%) and the only patient with spinal instability underwent level 2 laminectomy with no discectomy nor Modic changes at the time of surgery. His facet effusion was 1.50 mm; He had a dynamic angulation of 5 mm and no dynamic translation or vacuum sign. Mean facet effusion, dynamic angulation and dynamic translation in all patients were 1.56±0.58, 5±2.67 and 3 ± 0.51 mm, respectively.&lt;br /&gt;Conclusion: The findings of this study due to the very low prevalence of instability in 6-month follow-up cannot be used to draw a conclusion about the factors affecting lumbar instability and advanced studies are needed. However, the reasons for the very low prevalence of lumbar instability in this study may be related to surgical technique and a wide variety of other factors that can be compared with other studies with a higher prevalence of instability.</Abstract>
			<OtherAbstract Language="FA">Introduction: The aim of this study was to investigate the relationship between Modic changes and facet effusion and&lt;br /&gt;its relationship with lumbar spine stability in patients who underwent surgery for degenerative disorders.&lt;br /&gt;Materials and Methods: This observational study was performed on retrospectively collected data from the records of 116&lt;br /&gt;patients referred to Shahid Chamran Hospital in Shiraz between 2016 and 2019. Patients&#039; records were initially queried for demographic data, facet effusion extent, modic changes and type of operation. Patients underwent clinical examination and imaging after 6 months and spinal stability was assessed. Data analysis was performed using descriptive and inferential statistical tests.&lt;br /&gt;Results: The prevalence of 6-month instability in this study was very low (1 patient, 0.86%) and the only patient with spinal instability underwent level 2 laminectomy with no discectomy nor Modic changes at the time of surgery. His facet effusion was 1.50 mm; He had a dynamic angulation of 5 mm and no dynamic translation or vacuum sign. Mean facet effusion, dynamic angulation and dynamic translation in all patients were 1.56±0.58, 5±2.67 and 3 ± 0.51 mm, respectively.&lt;br /&gt;Conclusion: The findings of this study due to the very low prevalence of instability in 6-month follow-up cannot be used to draw a conclusion about the factors affecting lumbar instability and advanced studies are needed. However, the reasons for the very low prevalence of lumbar instability in this study may be related to surgical technique and a wide variety of other factors that can be compared with other studies with a higher prevalence of instability.</OtherAbstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Modic changes</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">fast effusion</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">spinal stability</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://jmj.jums.ac.ir/article_700540_d47ea3138f4f0512721231a99f8c72a9.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Jahrom University of Medical Sciences</PublisherName>
				<JournalTitle>Pars Journal of Medical Sciences</JournalTitle>
				<Issn>2717-0284</Issn>
				<Volume>20</Volume>
				<Issue>2</Issue>
				<PubDate PubStatus="epublish">
					<Year>2022</Year>
					<Month>08</Month>
					<Day>23</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Frequency of Gene-Producing Strains (aprA, rhlI, rhlR, algD) in Clinical Isolates of Pseudomonas aeruginosa, Isolated from Hospitals of South Fars</ArticleTitle>
<VernacularTitle>Frequency of Gene-Producing Strains (aprA, rhlI, rhlR, algD) in Clinical Isolates of Pseudomonas aeruginosa, Isolated from Hospitals of South Fars</VernacularTitle>
			<FirstPage>39</FirstPage>
			<LastPage>47</LastPage>
			<ELocationID EIdType="pii">700542</ELocationID>
			
<ELocationID EIdType="doi">10.22034/pjms.2022.700542</ELocationID>
			
			<Language>FA</Language>
<AuthorList>
<Author>
					<FirstName>Keramat</FirstName>
					<LastName>Dorri</LastName>
<Affiliation>PhD student, Department of Microbiology, College of Sciences, Agriculture and Modern Technology, Shiraz Branch, Islamic Azad University, Shiraz, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-5802-2216</Identifier>

</Author>
<Author>
					<FirstName>Farzan</FirstName>
					<LastName>Modarresi</LastName>
<Affiliation>Department of Bacteriology and Virology, Jahrom Medical School, Jahrom University of Medical Sciences,
Jahrom, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Mohammadreza</FirstName>
					<LastName>Shakibaie</LastName>
<Affiliation>Department of Microbiology and Virology, Kerman University of Medical Sciences, Kerman, Iran</Affiliation>
<Identifier Source="ORCID">0000-0003-2524-125X</Identifier>

</Author>
<Author>
					<FirstName>Elham</FirstName>
					<LastName>Moazamian</LastName>
<Affiliation>Department of Microbiology, College of Sciences, Agriculture and Modern Technology, Shiraz Branch, Islamic Azad University, Shiraz, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-4445-3971</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2022</Year>
					<Month>12</Month>
					<Day>25</Day>
				</PubDate>
			</History>
		<Abstract>Introduction: Antibiotic resistance and biofilm production are recognized as two significant factors in the pathogenesis of this bacterium, which are responsible for the long-term persistence of Pseudomonas aeruginosa infections. The present study is designed to examine the antibiotic resistance and the genes involved in the pathogenicity and resistance of this bacterium in the southern region of fars.&lt;br /&gt;Material and Methods: The isolates were detected and identified based on standard microbiological and biochemical methods. The antibiotic resistance pattern of Pseudomonas aeruginosa isolates was then determined by antibiotic&lt;br /&gt;susceptibility testing (AST) or the antibiogram (disk diffusion) test. The PCR technique was used to detect algD, rhlR, rhlL, and aprA genes.&lt;br /&gt;Results: In the study of antibiotic resistance of 40 isolates of Pseudomonas aeruginosa, the effective antibiotics in the treatment of this bacterium were Colistin with 0% resistance Polymyxin B 0%, Meropenem 1 isolate (2.5%), Ciprofloxacin 3 isolates (7.5%), Imipenem 3 isolates (7.5%) and Amikacin 3 isolates (7.5%). In the detection of algD, rhlR, rhlL and aprA genes, 100% of the isolates carried the algD gene, 96% of the isolates carried the rhlR gene, 94% of the isolates carried the rhlL gene and 91% of the isolates carried the aprA gene.&lt;br /&gt;Conclusion: The results demonstrated the high presence of algD, rhlR, rhlL, and aprA genes in the Pseudomonas aeruginosa isolates. Considering the high prevalence of the algD gene in the Pseudomonas aeruginosa strains of the current study, which is involved in the capsule production process, it seems essential and vital to control the infections of this bacterium due to the existence of multiple resistance and its ability to produce capsules.</Abstract>
			<OtherAbstract Language="FA">Introduction: Antibiotic resistance and biofilm production are recognized as two significant factors in the pathogenesis of this bacterium, which are responsible for the long-term persistence of Pseudomonas aeruginosa infections. The present study is designed to examine the antibiotic resistance and the genes involved in the pathogenicity and resistance of this bacterium in the southern region of fars.&lt;br /&gt;Material and Methods: The isolates were detected and identified based on standard microbiological and biochemical methods. The antibiotic resistance pattern of Pseudomonas aeruginosa isolates was then determined by antibiotic&lt;br /&gt;susceptibility testing (AST) or the antibiogram (disk diffusion) test. The PCR technique was used to detect algD, rhlR, rhlL, and aprA genes.&lt;br /&gt;Results: In the study of antibiotic resistance of 40 isolates of Pseudomonas aeruginosa, the effective antibiotics in the treatment of this bacterium were Colistin with 0% resistance Polymyxin B 0%, Meropenem 1 isolate (2.5%), Ciprofloxacin 3 isolates (7.5%), Imipenem 3 isolates (7.5%) and Amikacin 3 isolates (7.5%). In the detection of algD, rhlR, rhlL and aprA genes, 100% of the isolates carried the algD gene, 96% of the isolates carried the rhlR gene, 94% of the isolates carried the rhlL gene and 91% of the isolates carried the aprA gene.&lt;br /&gt;Conclusion: The results demonstrated the high presence of algD, rhlR, rhlL, and aprA genes in the Pseudomonas aeruginosa isolates. Considering the high prevalence of the algD gene in the Pseudomonas aeruginosa strains of the current study, which is involved in the capsule production process, it seems essential and vital to control the infections of this bacterium due to the existence of multiple resistance and its ability to produce capsules.</OtherAbstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Antibiotic resistance</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Pseudomonas aeruginosa</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">algD</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">rhlR</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">rhlI</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">aprA</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://jmj.jums.ac.ir/article_700542_1dfddfbb117d06df7631684b7c8bd51e.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Jahrom University of Medical Sciences</PublisherName>
				<JournalTitle>Pars Journal of Medical Sciences</JournalTitle>
				<Issn>2717-0284</Issn>
				<Volume>20</Volume>
				<Issue>2</Issue>
				<PubDate PubStatus="epublish">
					<Year>2022</Year>
					<Month>08</Month>
					<Day>23</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Prevalence of natural acquired immunity to Streptococcus pneumoniae in hemodialysis patients Jahrom-Iran, 2022</ArticleTitle>
<VernacularTitle>Prevalence of natural acquired immunity to Streptococcus pneumoniae in hemodialysis patients Jahrom-Iran, 2022</VernacularTitle>
			<FirstPage>48</FirstPage>
			<LastPage>54</LastPage>
			<ELocationID EIdType="pii">700543</ELocationID>
			
<ELocationID EIdType="doi">10.22034/pjms.2022.700543</ELocationID>
			
			<Language>FA</Language>
<AuthorList>
<Author>
					<FirstName>Masihollah</FirstName>
					<LastName>Shakeri</LastName>
<Affiliation>Zoonosis Research Center, Jahrom University of medical sciences, Jahrom, Iran</Affiliation>
<Identifier Source="ORCID">0000-0001-9184-9912</Identifier>

</Author>
<Author>
					<FirstName>Vahid</FirstName>
					<LastName>Rahmanian</LastName>
<Affiliation>Research Center for Social determinants of health, Jahrom University of medical sciences, Jahrom, Iran</Affiliation>
<Identifier Source="ORCID">0000-0003-3460-7495</Identifier>

</Author>
<Author>
					<FirstName>Nona</FirstName>
					<LastName>Hosseinnezhad</LastName>
<Affiliation>Zoonoses Research center, Jahrom University of medical sciences, Jahrom, Iran.</Affiliation>
<Identifier Source="ORCID">0000-0001-9293-4158</Identifier>

</Author>
<Author>
					<FirstName>Fatemeh</FirstName>
					<LastName>Sotoodeh Jahromi</LastName>
<Affiliation>Zoonoses Research center, Jahrom University of medical sciences, Jahrom, Iran</Affiliation>
<Identifier Source="ORCID">0000-0001-9293-4158</Identifier>

</Author>
<Author>
					<FirstName>Abdolreza</FirstName>
					<LastName>Sotoodeh Jahromi</LastName>
<Affiliation>Zoonoses Research center, Jahrom University of medical sciences, Jahrom, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-2131-2113</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2022</Year>
					<Month>12</Month>
					<Day>25</Day>
				</PubDate>
			</History>
		<Abstract>Introduction: Immune system disorders as one of the major problems in dialysis patients increase their susceptibility&lt;br /&gt;to pneumococcal pneumonia. The present study was conducted for the first time in Iran with the aim of determining the prevalence of natural acquired immunity to Streptococcus pneumoniae in hemodialysis patients in Jahrom, Iran.&lt;br /&gt;Material and Methods: This cross-sectional descriptive study was performed on 89 hemodialysis patients in Jahrom-Iran, 2022. The presence of anti-pneumococcal antibodies in the serum of patients was assessed by ELISA method. Demographic information, mean history of hemodialysis treatment and number of times per week were extracted from patients&#039; records. Data were analyzed using SPSS Statistics-23 statistical software (IBM,USA) using descriptive statistics, chi-square and Fisher&#039;s exact test.&lt;br /&gt;Results: The prevalence of immunity to Streptococcus pneumoniae in dialysis patients was 20.22%. There was a significant difference in the prevalence of pneumococcal immunity between participants in terms of age groups, sex and number of dialysis sessions per week (p&lt;0.05) but there was no statistically significant relationship with the duration of dialysis treatment (p=0.09).&lt;br /&gt;Conclusions: Prevalence of this type of immunity, which indicates a history of pneumococcal infection in dialysis patients in Jahrom. Due to the ability to prevent this infection by pneumococcal vaccination, the need for Iranian dialysis patients for pneumococcal vaccination is recommended.</Abstract>
			<OtherAbstract Language="FA">Introduction: Immune system disorders as one of the major problems in dialysis patients increase their susceptibility&lt;br /&gt;to pneumococcal pneumonia. The present study was conducted for the first time in Iran with the aim of determining the prevalence of natural acquired immunity to Streptococcus pneumoniae in hemodialysis patients in Jahrom, Iran.&lt;br /&gt;Material and Methods: This cross-sectional descriptive study was performed on 89 hemodialysis patients in Jahrom-Iran, 2022. The presence of anti-pneumococcal antibodies in the serum of patients was assessed by ELISA method. Demographic information, mean history of hemodialysis treatment and number of times per week were extracted from patients&#039; records. Data were analyzed using SPSS Statistics-23 statistical software (IBM,USA) using descriptive statistics, chi-square and Fisher&#039;s exact test.&lt;br /&gt;Results: The prevalence of immunity to Streptococcus pneumoniae in dialysis patients was 20.22%. There was a significant difference in the prevalence of pneumococcal immunity between participants in terms of age groups, sex and number of dialysis sessions per week (p&lt;0.05) but there was no statistically significant relationship with the duration of dialysis treatment (p=0.09).&lt;br /&gt;Conclusions: Prevalence of this type of immunity, which indicates a history of pneumococcal infection in dialysis patients in Jahrom. Due to the ability to prevent this infection by pneumococcal vaccination, the need for Iranian dialysis patients for pneumococcal vaccination is recommended.</OtherAbstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Natural Acquired Immunity</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Pneumococcus</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Streptococcus pneumoniae</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Hemodialysis</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Iran</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://jmj.jums.ac.ir/article_700543_d8ce25705f8355e4fa96da10b0d0fede.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Jahrom University of Medical Sciences</PublisherName>
				<JournalTitle>Pars Journal of Medical Sciences</JournalTitle>
				<Issn>2717-0284</Issn>
				<Volume>20</Volume>
				<Issue>2</Issue>
				<PubDate PubStatus="epublish">
					<Year>2022</Year>
					<Month>08</Month>
					<Day>23</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Association of interleukin-17 and phagosome with healing after acute myocardial infarction</ArticleTitle>
<VernacularTitle>Association of interleukin-17 and phagosome with healing after acute myocardial infarction</VernacularTitle>
			<FirstPage>55</FirstPage>
			<LastPage>61</LastPage>
			<ELocationID EIdType="pii">700546</ELocationID>
			
<ELocationID EIdType="doi">10.22034/pjms.2022.700546</ELocationID>
			
			<Language>FA</Language>
<AuthorList>
<Author>
					<FirstName>Mirzaali</FirstName>
					<LastName>Mofazzal Jahromi</LastName>
<Affiliation>Department of Immunology, School of Medicine, Jahrom University of Medical Sciences, Jahrom, Iran</Affiliation>
<Identifier Source="ORCID">0000-0001-7001-7842</Identifier>

</Author>
<Author>
					<FirstName>Kimia</FirstName>
					<LastName>Rasoolipoor</LastName>
<Affiliation>Student Research Committee, Jahrom University of Medical Sciences, Jahrom, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Zahra</FirstName>
					<LastName>Estakhr</LastName>
<Affiliation>Student Research Committee, Jahrom University of Medical Sciences, Jahrom, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Hamed</FirstName>
					<LastName>Mir</LastName>
<Affiliation>Research Center for Noncommunicable Diseases, Jahrom University of Medical Sciences, Jahrom, Iran</Affiliation>
<Identifier Source="ORCID">0000-0003-1267-5657</Identifier>

</Author>
<Author>
					<FirstName>Abazar</FirstName>
					<LastName>Roustazadeh</LastName>
<Affiliation>Department of Biochemistry and Nutrition, School of Medicine, Jahrom University of Medical Sciences,
Jahrom, Iran</Affiliation>
<Identifier Source="ORCID">0000-0003-1021-7687</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2022</Year>
					<Month>12</Month>
					<Day>25</Day>
				</PubDate>
			</History>
		<Abstract>Introduction: Acute myocardial infarction is one of the main causes of mortality in the worldwide. The aim of the present study is to predict the Association of interleukin (IL)-17 and phagosome with acute myocardial infarction.&lt;br /&gt;Materials and Methods: Microarray data were extracted from National Center for Biotechnology Information (NCBI) and then analyzed by GEO2R and R softwares. The functional analysis of up/down regulation of genes were performed using DAVID and Enrichr data bases.&lt;br /&gt;Results: In this study, expression of 208 genes were lower in patients group compared to the controls (Log2FC&lt;-1). In patients’ group, PAQR8, CCR2, CCR5, and ZNF137P genes significantly had lower expression. Although 528 gens, especially NR4A2, GABARAPL1, THBD, NFIL3, and MAFB significantly had more expression compared to the controls (Log2FC&gt;+1). KEGG analysis on gens that increase expression showed that signaling pathways of IL-17 and phagosome are two pathways in patients with acute myocardial infarction.&lt;br /&gt;Conclusion: According to our finding, after acute myocardial infarction, inflammatory pathway like IL-17 signaling&lt;br /&gt;recruiting matrix metalloproteinase 9 as a protein involve in repairing acute myocardial infarction damages. Also, the phagosome activity by major histocompatibility complex class-II (MHC-II) and CD36 signaling pathways, may be played a role in accelerating healing after acute myocardial infarction damages.&lt;br /&gt; </Abstract>
			<OtherAbstract Language="FA">Introduction: Acute myocardial infarction is one of the main causes of mortality in the worldwide. The aim of the present study is to predict the Association of interleukin (IL)-17 and phagosome with acute myocardial infarction.&lt;br /&gt;Materials and Methods: Microarray data were extracted from National Center for Biotechnology Information (NCBI) and then analyzed by GEO2R and R softwares. The functional analysis of up/down regulation of genes were performed using DAVID and Enrichr data bases.&lt;br /&gt;Results: In this study, expression of 208 genes were lower in patients group compared to the controls (Log2FC&lt;-1). In patients’ group, PAQR8, CCR2, CCR5, and ZNF137P genes significantly had lower expression. Although 528 gens, especially NR4A2, GABARAPL1, THBD, NFIL3, and MAFB significantly had more expression compared to the controls (Log2FC&gt;+1). KEGG analysis on gens that increase expression showed that signaling pathways of IL-17 and phagosome are two pathways in patients with acute myocardial infarction.&lt;br /&gt;Conclusion: According to our finding, after acute myocardial infarction, inflammatory pathway like IL-17 signaling&lt;br /&gt;recruiting matrix metalloproteinase 9 as a protein involve in repairing acute myocardial infarction damages. Also, the phagosome activity by major histocompatibility complex class-II (MHC-II) and CD36 signaling pathways, may be played a role in accelerating healing after acute myocardial infarction damages.&lt;br /&gt; </OtherAbstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Acute Mocardial Infarction</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">IL-17</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Phagosome</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Microarray</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://jmj.jums.ac.ir/article_700546_84fde39fda2f6435aa6575dd3c06fe93.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Jahrom University of Medical Sciences</PublisherName>
				<JournalTitle>Pars Journal of Medical Sciences</JournalTitle>
				<Issn>2717-0284</Issn>
				<Volume>20</Volume>
				<Issue>2</Issue>
				<PubDate PubStatus="epublish">
					<Year>2022</Year>
					<Month>08</Month>
					<Day>23</Day>
				</PubDate>
			</Journal>
<ArticleTitle>In vitro effect of essential oil and methanol, ethyl acetate and hexane extracts of Ferulago angulata on Trichomonas vaginalis protozoan</ArticleTitle>
<VernacularTitle>In vitro effect of essential oil and methanol, ethyl acetate and hexane extracts of Ferulago angulata on Trichomonas vaginalis protozoan</VernacularTitle>
			<FirstPage>62</FirstPage>
			<LastPage>69</LastPage>
			<ELocationID EIdType="pii">700531</ELocationID>
			
<ELocationID EIdType="doi">10.22034/pjms.2022.700531</ELocationID>
			
			<Language>FA</Language>
<AuthorList>
<Author>
					<FirstName>Mehdi</FirstName>
					<LastName>Akbari</LastName>
<Affiliation>Department of Medical Parasitology and Mycology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-6514-9119</Identifier>

</Author>
<Author>
					<FirstName>Dara</FirstName>
					<LastName>Dastan</LastName>
<Affiliation>Medicinal Plants and Natural Products Research Center, Hamadan University of Medical Sciences, Hamadan, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-7208-208X</Identifier>

</Author>
<Author>
					<FirstName>Mohammad</FirstName>
					<LastName>Fallah</LastName>
<Affiliation>Department of Medical Parasitology and Mycology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Mohammad</FirstName>
					<LastName>Matini</LastName>
<Affiliation>Department of Medical Parasitology and Mycology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2022</Year>
					<Month>12</Month>
					<Day>25</Day>
				</PubDate>
			</History>
		<Abstract>Introduction: Trichomoniasis is the most common non-viral sexually transmitted infection in the world, with resistant&lt;br /&gt;cases spreading. The aim of this study was to evaluate the effect of Ferulago angulata extracts and essential oil on Trichomonas vaginalis protozoan.&lt;br /&gt;Materials and Methods: In this study, methanol, ethyl acetate and hexane extracts and essential oil of F. angulata aerial parts were prepared and tested to determine the minimum lethal concentration (MLC) and the percentage of growth inhibition (GI%). The tests were carried out on two clinical isolates of T. vaginalis under aerobic conditions and against metronidazole and control. The tests were surveyed after 24 and 48 hours of incubation.&lt;br /&gt;Results: After 24 hours, the MLC of methanol, ethyl acetate and hexane extracts and essential oil were 250, 500, 250 and 500 μg/ml, respectively. The MLC of ethyl acetate and hexane extracts were reduced to 250 and 125 μg/ml, after 48 hours. GI% at Sub-MLC for extracts and essential oils were 39.3% to 93.2%, after 24 hours, and from 51.6% to 95.1% after 48 hours. Also, the mean MLCs of metronidazole after 24 and 48 hours were 9.3 and 4.6 μg/ml.&lt;br /&gt;Conclusion: The results of this study showed that F. angulata has anti-trichomonial potential. Thus, more investigations it is necessary to purify the constituents of essential oil and extracts. Further in vitro and in vivo experiments will clarify the antimicrobial potential of the plant to make a more correct judgment.</Abstract>
			<OtherAbstract Language="FA">Introduction: Trichomoniasis is the most common non-viral sexually transmitted infection in the world, with resistant&lt;br /&gt;cases spreading. The aim of this study was to evaluate the effect of Ferulago angulata extracts and essential oil on Trichomonas vaginalis protozoan.&lt;br /&gt;Materials and Methods: In this study, methanol, ethyl acetate and hexane extracts and essential oil of F. angulata aerial parts were prepared and tested to determine the minimum lethal concentration (MLC) and the percentage of growth inhibition (GI%). The tests were carried out on two clinical isolates of T. vaginalis under aerobic conditions and against metronidazole and control. The tests were surveyed after 24 and 48 hours of incubation.&lt;br /&gt;Results: After 24 hours, the MLC of methanol, ethyl acetate and hexane extracts and essential oil were 250, 500, 250 and 500 μg/ml, respectively. The MLC of ethyl acetate and hexane extracts were reduced to 250 and 125 μg/ml, after 48 hours. GI% at Sub-MLC for extracts and essential oils were 39.3% to 93.2%, after 24 hours, and from 51.6% to 95.1% after 48 hours. Also, the mean MLCs of metronidazole after 24 and 48 hours were 9.3 and 4.6 μg/ml.&lt;br /&gt;Conclusion: The results of this study showed that F. angulata has anti-trichomonial potential. Thus, more investigations it is necessary to purify the constituents of essential oil and extracts. Further in vitro and in vivo experiments will clarify the antimicrobial potential of the plant to make a more correct judgment.</OtherAbstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Ferulago angulata</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Trichomonas vaginalis</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Extract</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">essential oil</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://jmj.jums.ac.ir/article_700531_a49972fe89c39eefd2e184713fda634f.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
